These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2496774)

  • 1. Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat.
    Larsen GR; Metzger M; Henson K; Blue Y; Horgan P
    Blood; 1989 May; 73(7):1842-50. PubMed ID: 2496774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits.
    Collen D; Stassen JM; Larsen G
    Blood; 1988 Jan; 71(1):216-9. PubMed ID: 3120823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator.
    Hansen L; Blue Y; Barone K; Collen D; Larsen GR
    J Biol Chem; 1988 Oct; 263(30):15713-9. PubMed ID: 3139674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
    Langer-Safer PR; Ahern TJ; Angus LB; Barone KM; Brenner MJ; Horgan PG; Morris GE; Stoudemire JB; Timony GA; Larsen GR
    J Biol Chem; 1991 Feb; 266(6):3715-23. PubMed ID: 1847387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein engineering of novel plasminogen activators with increased thrombolytic potency in rabbits relative to activase.
    Larsen GR; Timony GA; Horgan PG; Barone KM; Henson KS; Angus LB; Stoudemire JB
    J Biol Chem; 1991 May; 266(13):8156-61. PubMed ID: 1708773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosis.
    Cambier P; van de Werf F; Larsen GR; Collen D
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):468-72. PubMed ID: 2453751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin affinity and clearance of t-PA deletion and substitution analogues.
    Johannessen M; Diness V; Pingel K; Petersen LC; Rao D; Lioubin P; O'Hara P; Mulvihill E
    Thromb Haemost; 1990 Feb; 63(1):54-9. PubMed ID: 2111048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
    Warshawsky I; Bu G; Schwartz AL
    J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells.
    Spellman MW; Basa LJ; Leonard CK; Chakel JA; O'Connor JV; Wilson S; van Halbeek H
    J Biol Chem; 1989 Aug; 264(24):14100-11. PubMed ID: 2503511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis in human tissue-plasminogen activator. Distinguishing sites in the amino-terminal region required for full fibrinolytic activity and rapid clearance from the circulation.
    Ahern TJ; Morris GE; Barone KM; Horgan PG; Timony GA; Angus LB; Henson KS; Stoudemire JB; Langer-Safer PR; Larsen GR
    J Biol Chem; 1990 Apr; 265(10):5540-5. PubMed ID: 2108143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer thrombolytic agents.
    Verstraete M
    Ann Acad Med Singap; 1999 May; 28(3):424-33. PubMed ID: 10575530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells.
    Bergwerff AA; van Oostrum J; Asselbergs FA; Bürgi R; Hokke CH; Kamerling JP; Vliegenthart JF
    Eur J Biochem; 1993 Mar; 212(3):639-56. PubMed ID: 8462541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
    Smedsrød B; Einarsson M
    Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator.
    Hotchkiss A; Refino CJ; Leonard CK; O'Connor JV; Crowley C; McCabe J; Tate K; Nakamura G; Powers D; Levinson A
    Thromb Haemost; 1988 Oct; 60(2):255-61. PubMed ID: 2851193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
    Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
    Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
    Yahara H; Matsumoto K; Maruyama H; Nagaoka T; Ikenaka Y; Yajima K; Fukao H; Ueshima S; Matsuo O
    Thromb Haemost; 1994 Dec; 72(6):893-9. PubMed ID: 7740460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of drug disposition between wild-type and novel tissue-type plasminogen activator pamiteplase in rats.
    Oikawa K; Watanabe T; Higuchi S
    Drug Metab Dispos; 2000 Sep; 28(9):1087-93. PubMed ID: 10950854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
    Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
    Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.